Hong Kong · Delayed Price · Currency is HKD Fusen Pharmaceutical Company Company Description
Fusen Pharmaceutical Company Limited, an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.
The company’s product portfolio includes Shuanghuanglian oral solutions and Shuanghuanglian injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; nicardipine hydrochloride injections; and other products.
It also offers small and large volume injections, oral liquids, tablets, capsules, granules, traditional Chinese medicine extracts, and chemical synthesis.
In addition, the company provides business management and consulting services; and engages in the sale of construction material and electricity.
It offers its medicines for the treatment of heat-clearing and detoxification, cardiovascular and cerebrovascular, antihypertensive and hypoglycemic, tonifying, qi-regulating, anti-anemia, and antibacterial and anti-inflammatory.
Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
| Country | Cayman Islands |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,131 |
| CEO | Zhiming Cao |
Contact Details
Address: Urban Industrial Zone Nanyang China | |
| Website | fusenyy.com |
Stock Details
| Ticker Symbol | 1652 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG370981030 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhiming Cao | Chief Executive Officer and Executive Chairman |
| Taisheng Hou | Executive Director |
| Yongsheng Chi | Executive Director |
| Qingfen Meng | Executive Director |
| Zhen Li | Chief Financial Officer |
| Yuk Hong Yeung | Company Secretary |